Sanzgiri U Y, Srivatsan V, Muralidhara S, Dallas C E, Bruckner J V
Department of Pharmacology and Toxicology, College of Pharmacy, University of Georgia, Athens 30602-2356, USA.
Toxicol Appl Pharmacol. 1997 Mar;143(1):120-9. doi: 10.1006/taap.1996.8079.
Carbon tetrachloride (CCl4) has been studied extensively for its hepatotoxic effects. There is a paucity of information, however, about its tissue deposition following administration by different routes and patterns of exposure. The specific objective of this study was to delineate the uptake, distribution, and elimination of CCl4 in tissues of rats subjected to equivalent oral and inhalation exposures. Male Sprague-Dawley rats (325-375 g) were exposed to 1000 ppm CCl4 for 2 hr. The total absorbed dose (179 mg CCl4/kg bw) was administered to other groups of rats as a single oral bolus or by constant gastric infusion over a period of 2 hr. Animals were terminated at selected time intervals during and postexposure and tissues (liver, kidney, lung, brain, fat, skeletal muscle, spleen, heart, and GI tract) removed for measurement of their CCl4 content by headspace gas chromatography. CCl4 levels in all tissues were much lower in the gastric infusion group than in the oral bolus and inhalation groups. Inhalation resulted in relatively high tissue CCl4 concentrations, because inhaled chemicals enter the arterial circulation and are transported directly to organs throughout the body. It seems logical that the liver should accumulate more CCl4 following ingestion than following inhalation. This did not prove to be the case when comparing liver AUC values for the gastric infusion and inhalation groups. Substantially lower CCl4 concentrations in the liver of animals in the gastric infusion group appeared to be due to very rapid metabolic clearance of the relatively small amounts of CCl4 entering the liver over the 2-hr infusion period. It was hypothesized that the capacity of first-pass hepatic and pulmonary elimination could be exceeded, if CCl4 were given as a single, large oral bolus. Indeed, deposition of CCl4 in all tissues was greater in the oral bolus group than in the gastric infusion group. The time courses of uptake and elimination of CCl4 appeared to be governed largely by a tissue's rate of blood perfusion and lipid content. CCl4 was rapidly taken up, for example, by the brain and liver. These organs' CCl4 content then diminished, as CCl4 was metabolized and redistributed to adipose tissue. CCl4 accumulated slowly, but to very high concentrations, in fat and remained elevated for a prolonged period. Thus, concentrations of CCl4 in some tissues may not be reflective of blood levels. The most appropriate measure of internal dose for CCl4 acute hepatotoxicity appears to be the area under tissue concentrations versus time curve from 0 to 30 min. Tissue time-course data sets are essential for the refinement and validation of physiological models for CCl4 and other volatile organic chemicals.
四氯化碳(CCl4)的肝毒性作用已得到广泛研究。然而,关于其通过不同途径给药和暴露模式后的组织沉积情况,相关信息却很匮乏。本研究的具体目的是描绘在等效口服和吸入暴露条件下,大鼠组织中四氯化碳的摄取、分布和消除情况。雄性斯普拉格 - 道利大鼠(体重325 - 375克)暴露于1000 ppm的四氯化碳中2小时。将总吸收剂量(179毫克四氯化碳/千克体重)以单次口服推注或在2小时内持续胃灌注的方式给予其他几组大鼠。在暴露期间及暴露后选定的时间间隔处死动物,取出组织(肝脏、肾脏、肺、脑、脂肪、骨骼肌、脾脏、心脏和胃肠道),通过顶空气相色谱法测量其中四氯化碳的含量。胃灌注组所有组织中的四氯化碳水平均远低于口服推注组和吸入组。吸入导致组织中四氯化碳浓度相对较高,因为吸入的化学物质进入动脉循环并直接输送到全身各器官。摄入后肝脏应比吸入后积累更多四氯化碳,这似乎合乎逻辑。但比较胃灌注组和吸入组的肝脏曲线下面积(AUC)值时,情况并非如此。胃灌注组动物肝脏中四氯化碳浓度显著较低,似乎是由于在2小时灌注期内进入肝脏的相对少量四氯化碳被非常迅速地代谢清除。据推测,如果以单次大剂量口服推注的方式给予四氯化碳,肝脏和肺的首过消除能力可能会被超过。事实上,口服推注组所有组织中四氯化碳的沉积量均大于胃灌注组。四氯化碳的摄取和消除时间进程似乎很大程度上受组织的血液灌注速率和脂质含量控制。例如,大脑和肝脏能迅速摄取四氯化碳。随着四氯化碳被代谢并重新分布到脂肪组织中,这些器官中的四氯化碳含量随后会减少。四氯化碳在脂肪中积累缓慢,但浓度非常高,且长时间保持在较高水平。因此,某些组织中四氯化碳的浓度可能无法反映血液水平。对于四氯化碳急性肝毒性而言,最合适的内剂量衡量指标似乎是0至30分钟内组织浓度与时间曲线下的面积。组织时间进程数据集对于完善和验证四氯化碳及其他挥发性有机化合物的生理模型至关重要。